Bain Capital Life Sciences Investors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.55M | Hold |
|
|||||
|
2022
Q4 | $2.41M | Hold |
|
|||||
|
2022
Q3 | $2.81M | Hold |
|
|||||
|
2022
Q2 | $2.7M | Buy |
|
|||||
|
2022
Q1 | $6.55M | Hold |
|
|||||
|
2021
Q4 | $13.5M | Hold |
|
|||||
|
2021
Q3 | $22.6M | Buy |
|
|||||
|
2021
Q2 | $18.8M | Hold |
|
|||||
|
2021
Q1 | $21.4M | Hold |
|
|||||
|
2020
Q4 | $21.2M | Hold |
|
|||||
|
2020
Q3 | $19.1M | Hold |
|
|||||
|
2020
Q2 | $25M | Buy |
|